Mutual Funds Commodities Research Tax Planning IPO Our Team Contact Us    
Google
Web www.equitybulls.com
Stock Report

| More

Combat Drugs Ltd approves proposal for takeover of Limited Liability Company in the USA

Posted On: 2019-08-12 22:05:14

The Board of Directors of Combat Drugs Ltd at its meeting held today, 12th August, 2019, have considered the proposal for acquisition of a Limited Liability Company (LLC) (hereinafter referred to as the "Target Company") based in the United States of America.

The target company is operating in the field of Information Technology Services specializing in ERP Solutions, Business Intelligence, Data Warehousing, Software Development, Consulting, Programming and Offshore Development, having an Income Revenue of USD $11.86 Million (approx Rs.81.83 Crores at Rs.69.00 per US dollar) and a Gross Profit of USD $0.773 Million (approx Rs.5.33 Crores at Rs.69.00 per US dollar) as of their Financial Year ended 31st December, 2018. The Target company has clients in Healthcare, Hospitality, Financial services etc ranging from small businesses to Fortune 1000 companies including clients such as Merck, Allregan, Bank of America, SAP, IBM, among others.

The Board with a view of making the company's global presence in the field of Pharma and Information Technology, is considering the proposal of the acquisition of the target company, subject to Due Diligence of the Target company and its authorized representatives and the Feasibility and Viability report.

The Board has authorized its Promoter Mr. Janakiram Ajjarapu and/or its Director/s to conduct and/or appoint an agency for the Feasibility and Technical and Financial Due Diligence of the project and detailed discussions with the Promoters of the target company and their bankers, Creditors and Debtors thereof and making representations, for obtaining statutory approvals, wherever necessary.

The Board also considered the proposal for the change of the Company's name to bring it in sync with the diversified interests of the company. The Board will put forth the same, in the ensuing Annual General Meeting for the approval of the Shareholders of the company along with other relevant proposed resolutions and, for submission of other necessary approvals.

Shares of COMBAT DRUGS LTD. was last trading in BSE at Rs.23.3 as compared to the previous close of Rs. 24.5. The total number of shares traded during the day was 5581 in over 3 trades.

The stock hit an intraday high of Rs. 23.3 and intraday low of 23.3. The net turnover during the day was Rs. 130037.


Source: Equity Bulls

Click here to send ur comments or to feedback@equitybulls.com





Other Headlines:

SPARC to Provide Update on R&D Pipeline

Biocon's Malaysia Insulin Glargine Manufacturing Facility Receives EU GMP Certification

ICRA A1+ rating reaffirmed for Karur Vysya Bank's Certificates of Deposit

EIH Associated Hotels Ltd updates on renovation of Trident Udaipur

CRISIL A1+ rating assigned to CPs of PNB Gilts Ltd

Infosys Expands Strategic Partnership with Google Cloud

Steep Price Movement in Equity Shares of Tiger Logistics (India) Limited

CRISIL reaffirms rating of Tasty Dairy Specialities Limited

Ind-Ra revises BHEL's outlook to Negative

Procter & Gamble Hygiene and Health Care Ltd board recommends final dividend of Rs. 48

TCS' New York City Marathon App Wins Gold in Best in Biz Awards 2019 International

CRISIL reaffirms ratings of NCL Industries Ltd

Ashoka Metcast Ltd arm commissions steel rolling mill

V-Mart Retail Ltd opens three new stores in Nagaland, Jharkhand and Rajasthan

NMDC Ltd revises prices of Iron Ore w.e.f. 20-08-2019

Lactose India Ltd repays entire loan amount of Rs. 43 crores to Piramal

Procter & Gamble Hygiene and Health Care Ltd Q4 Sales up 20% for the fiscal ended June 30, 2019

Zydus receives final approval from the USFDA for Ranolazine Extended-Release Tablets

Domino's Pizza now in Agartala

Hon'ble Prime Minister of India inaugurates 4x180 MW Mangdechhu HEP, Bhutan, commissioned by BHEL

Introducing Maruti Suzuki NEXA's new premium MPV, the XL6

ITC Classmate Launches 'Pulse 3D Notebooks' for the Youth

Dhunseri Tea & Industries Ltd completes deal with Tata Global Beverages Ltd

BookMyForex Partners with YES Bank to Launch Forex Card on Visa network

Zydus announces patient enrollment in EVIDENCES VII Phase 2 clinical trial of Saroglitazar Magnesium in NAFLD with PCOS

Mindtree Named U.S. Market Leader in IoT Consulting and Services by ISG

CARE reaffirms rating of Gati Ltd

Bank of Baroda board to consider raising capital

HCL Technologies Launches Delivery Centre in New Zealand to support growing customer and partner ecosystem

Mahindra Logistics strengthens its partnership with the Volkswagen Group India

Zomato Partners with FarEye to Gain Logistics Visibility & Enhance Restaurant Compliance

KRBL Ltd obtains trade mark registration of 'INDIA GATE' brand

ICRA upgrades ratings of Deepak Nitrite Ltd

Successful US FDA Inspection at Alembic Pharmaceuticals Bioequivalence Facility at Vadodara

'Radio City Super Singer', India's Biggest Singing Platform Launches Its 11th Season to Encourage Aspiring Singers

Freshtrop Fruits Ltd board to consider buy back proposal

Sun Pharma Advanced Research Company Limited updates on Taclantis®

N K Industries Ltd board to consider voluntary delisting

Zensar partners with Aptos to deliver next-gen retail innovation

Gufic Biosciences Ltd board recommends dividend of Rs. 0.05

TVS Srichakra Ltd Launches Brand TVS Eurogrip: Aimed At Millennials

SpiceJet to shift its entire operations at Mumbai to Terminal 2 from October 1

HFCL receives its largest ever single Purchase Order

Thomas Cook India taps into strong appetite for travel beyond the traditional summer vacation

ICRA reaffirms rating of Sayaji Industries Ltd

NIIT and Automation Anywhere Collaborate to Launch Robotic Process Automation Workshops

ICRA revises ratings of Sical Logistics Ltd

Acuite reaffirms rating of Capital India Finance Ltd

Loyal Equipments Ltd receives order worth Rs. 10.16 crore

Nile Ltd fixes Sep 23, 2019 as record date for final dividend







Website Created & Maintained by : Chennai Scripts
West Mambalam, Chennai - 600 033,
Tamil Nadu, India

disclaimer copyright © 2005 - 2019